Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bailey Vaselkiv

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Prostate|May 21, 2025
Survival Outcomes for Rural Patients With Advanced Prostate Cancer: A SEER InvestigationLiang G Qu, J Bailey Vaselkiv, Marlon Perera, et al.
European Urology Oncology|December 31, 2021
p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-upKonrad H Stopsack, Daniela Correia Salles, J Bailey Vaselkiv, et al.
British Journal of Cancer|October 29, 2023
Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsyXiaoshuang Feng, Yiwen Zhang, J Bailey Vaselkiv, et al.
Elife|December 23, 2021
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarraysKonrad H Stopsack, Svitlana Tyekucheva, Molin Wang, et al.
Molecular Cancer Research : MCR|September 20, 2022
Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS FusionsKonrad H Stopsack, Xiaofeng A Su, J Bailey Vaselkiv, et al.
American Journal of Epidemiology|April 30, 2025
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancerZhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Prostate|May 21, 2025
Survival Outcomes for Rural Patients With Advanced Prostate Cancer: A SEER InvestigationLiang G Qu, J Bailey Vaselkiv, Marlon Perera, et al.
European Urology Oncology|December 31, 2021
p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-upKonrad H Stopsack, Daniela Correia Salles, J Bailey Vaselkiv, et al.
British Journal of Cancer|October 29, 2023
Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsyXiaoshuang Feng, Yiwen Zhang, J Bailey Vaselkiv, et al.
Elife|December 23, 2021
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarraysKonrad H Stopsack, Svitlana Tyekucheva, Molin Wang, et al.
Molecular Cancer Research : MCR|September 20, 2022
Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS FusionsKonrad H Stopsack, Xiaofeng A Su, J Bailey Vaselkiv, et al.
American Journal of Epidemiology|April 30, 2025
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancerZhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, et al.
Pageof 1